MeSH tree: N05
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a new study by Weill Cornell ...
Jul 7, 2026
0
14
A new nationwide study from the University of Sydney analyzed the health records of more than 4.4 million older Australians (65 years and over) and found that more than three-quarters are living with multiple chronic conditions, ...
Jul 7, 2026
0
3
Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine ...
Jul 7, 2026
0
5
For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue of the New England Journal of Medicine.
Jul 6, 2026
0
3
At least 500 people have died out of over 1,500 confirmed cases in Congo's Ebola outbreak, authorities said, as frontline workers threatened to go on strike on Monday over unpaid benefits and poor working conditions.
Jul 6, 2026
0
2
Glaucoma is the leading cause of irreversible visual impairment worldwide. Because the disease often progresses without symptoms for years, many patients are diagnosed only after permanent damage to the optic nerve has already ...
Jul 5, 2026
0
14
A 10-year national study has found improved antimicrobial use in Australian hospitals that regularly monitored their prescribing, using a globally unique program developed by a Melbourne hospital. The study reinforces the ...
Jul 3, 2026
0
4
A pioneering food additive that can stop people from gaining weight has appeared on the EU's Novel Food List, indicating its safety for human consumers. Inulin propionate ester, or IPE, is a dietary fiber developed and tested ...
Jul 2, 2026
0
104
For patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), adding pirtobrutinib to venetoclax-rituximab (PVR) yields improved progression-free survival (PFS) compared to venetoclax-rituximab (VR), according ...
Jul 2, 2026
0
3
Over the decade from 2014 to 2023, Mexico's infant death rate barely budged, suggesting the country hit a wall in saving babies' lives—even as official paperwork claimed that almost all babies had a medical professional present ...
Jul 2, 2026
0
2
